2017 EVIDENCE USA SPEAKERS
Rafael Alfonso, Director, Analytics and Innovation, Value Evidence and Outcomes, GSK
Rachel is a Director of Payer Policy and Health Outcomes on the Payer Relations and Reimbursement Team at Foundation Medicine. She leads the development of US HEOR initiatives and is focused on payer education about the unique clinical value of comprehensive genomic profiling. Her professional...
Rachel Anhorn, Director, Payer Policy and Health Outcomes, Foundation Medicine Inc
Bhakti Arondekar, Senior Director, Global & US Immuno/Oncology Team Leader, Outcomes & Evidence, Pfizer
James Barbeau, Director of Clinical Pathology, Lifespan/Brown University
Lauren Bartolome, HEOR Fellow, Novartis
Alberto Batista, HEOR Fellow, Jefferson College of Population Health
Elise Berliner, Ph.D., is the Director of the Technology Assessment Program at the Agency for Healthcare Research and Quality (AHRQ). The Technology Assessment program provides technology assessments to the Centers for Medicare & Medicaid Services (CMS) to inform Medicare coverage decisions and ...
Elise Berliner, Ph.D., Director, Technology Assessment Programme, Agency for Healthcare Research and Quality - U.S. Department of Health and Human Services
Jason Booth, Global Health Economics and Outcomes Research Lead, Oncology, Shire Pharmaceuticals
Ms. Bragg frequently represents pharmaceutical, medical device and food companies in crisis management situations related to products that have manufacturing or quality issues, helping them navigate the myriad of matters that arise in the context of product recalls, and also counsels on...
Jennifer Bragg, Partner, Skadden Arps Slate Meagher & Flom LLP
Dr. Brod received his medical degree from the University of Pennsylvania and completed his residency in Dermatology at the University of Pittsburgh after completing a one-year internship in Internal Medicine at Brown University. He was Board certified in Dermatology in 1991 and recertified in...
Bruce Broad, Clinical Professor of Dermatology at Perelman School of Medicine, University of Pennsylvania
Catherine Brownstein, Scientific Director, Manton Center for Orphan Disease Research
Hassan Bruneo, Associate Director, Alnylam
Anna Bucsics, Project Advisor, University of Vienna
Francisco Burgin, PGY-1 Managed Care Pharmacy Resident, Humana
Yong Chen, Director of Real World Data & Analytics, GSK
Steve Clark, Vice President of Business Development and Consulting, Optum Life Sciences
Aimee Coughlin, mktg, Optum Life Sciences
Mark Cziraky, Vice President of Researce Healthcore, Anthem
Keely Dahl, Associate Medical Director Biologics, Novo Nordisk
David Davidovic has been involved in the commercialization of products and in building best-in-class commercial capabilities in the pharmaceutical and biotechnology industries for over 37 years. Most recently, David was Vice President and Global Head of Commercial Services for Roche and...
David Davidovic, Founder, pathForward, Former VP and Global Head, Commercial Services, Roche Genentech
Jill Davies, COO, Gene Matters
Peter Dehnel, Medical Director, Blue Cross and Blue Shield of Minnesota
Riad Dirani, PhD, is currently the VP of Global Health Economic and Outcomes Research at Teva Pharmaceuticals. His responsibilities include overseeing the establishment of this function within Medical Affairs, and developing the strategic capabilities for HEOR to optimize the development and...
Riad Dirani, Riad Dirani, Vice President, Global Health Economics and Outcomes Research, Teva Pharmaceuticals
Tao Fan, Director of Evidence Based Medicine and Medical Affairs, Sanofi Inc
Susan Gabriel, Director of Global Health Economics and Outcomes Research and Oncology, Teva Pharmaceutical Industries
Dr. Gaebler was Senior Director, Global Medical Outcomes Strategy at Biogen Idec, Inc., where she provided strategic leadership and technical expertise to ensure that global medical product strategies and tactics integrate the evolving demands of the global payer landscape. As Director, Global...
Julia Gaebler, Former Senior Director of Global Medical Outcomes Strategy, Biogen Idec
Pamela Gavin, Chief Operating Officer, National Organization for Rare Disorders
Bill GoodsonDirector, Market Access and Reimbursement ServicesEisai Dec 2015-Present: Director Market Access and Reimbursement Services – EisaiDec 2013-Dec 2015: Deputy Director Patient Access Services - BayerNov 2011-Nov 2013: Deputy Director Pricing and Reimbursement and Patient Assistance...
Bill Goodson, Deputy Director of Pricing Reimbursement and Patient Assistance, Eisai
Andy Gunn, Global Head Evidence Generation, UCB Pharma
Michelle Guo, Manager Real World Data Scientist, GSK
James Harnett, Sr. Director, Analytical Sciences Lead, Real World Data and Analytics, Global Health and Value, Pfizer
Since late 2013, Katherine Hempstead, PhD, has directed the Robert Wood Johnson Foundation’s work on coverage. In addition, Hempstead works on issues related to health care price transparency and value. She joined the Foundation in 2011 as a senior program officer in the Research and Evaluation...
Katherine Hempstead, Senior Adviser to the Executive Vice President, Robert Wood Johnson Foundation
Athula Herath, PhD, MBCS, CITP, CEngAthula Herath is the Global Head of Real World Evidence Epidemiology and affiliated with the Center of Excellence for Real World Evidence at Novartis. Prior to that, Athula worked for 10 years as Statistical Director for Medimmune/AstraZeneca. Athula joined...
Athula Herath, Global Head of Real world Evidence Disease Epidemiology, Novartis
Ravi Iyer, Director Global Health Economics and Reimbursement, Teva
Dr. Jonathan P. Jarow is currently the senior medical advisor to the Center Director in CDER at FDA. Jonathan previously served as the director of CDER’s Office of Medical Policy, chair of the Medical Policy Council, and as deputy director of the Office of Hematology and Oncology Products. He is...
Jonathan Jarrow, Senior Medical Advisor to the Center Director of CDER, F.D.A
Ashley John, Senior Specialist, Advocacy and Policy, American Academy of Dermatology
Sachin Kamal-Bahl, Vice President & Head, Global Health & Value Innovation Center, Pfizer
Adam Kautzner, Vice President, Formulary & Drug Trends Solutions, Express Scripts
Designed, implemented a data collection procedure and responsible for working with several Rare Patient Advocacy groups/non-profits/patients and Medical Institutions in the USA and Internationally to capture, aggregate and store all patient Institutional Medical Health Data. Compiled an...
Karen Keeley, Consultant, R.A.R.E. Science
Mr. Klein brings over 35 years of experience in health care and information technology services to the Patient Access Network (PAN) Foundation. Mr. Klein came to the PAN Foundation from the Cystic Fibrosis (CF) Foundation, where he served as Senior Vice President for the CF Services pharmacy and...
Dan Klein, President and Chief Executive Officer, Patient Access Network Foundation
Mr. Koester is the Managing Partner, OHWK Business Management Advisory. His professional background includes extensive business management consulting experience to global pharmaceutical manufacturers in the functional areas of Canadian health technology assessment, price negotiations, market...
Olaf Koester, Director, Manitoba Health
Brett Kopelan, Executive Director, DebRa of America
Currently leads the Global Health Economics, Market Access and reimbursement Strategy at CSL Behring. In the past Lead US HEOR and epidemiology team at GSK to support Vaccines, And supported Diabetes and Metabolism at Merck portfolio at Merck and BMS
Shanthy Krishnaraja, Head of Global Health Economics and Reimbursement Strategy, C.S.L. Behring
Sonia Lee, HEOR Fellow, Ethicon Inc
Simon Lin, Chief Research Information Officer, Nationwide Children's Hospital
Julie Locklear, Vice President and Head of Health Economics and Outcomes Research, EMD Serono
Ben locwin, Ex-Executive Director Roche President, Healthcare Science Advisors, Roche & Genentech
Marianne Lopez, Research Director, Duke-Robert J. Margolis, MD, Center for Health Policy
Christine Lu MSc, PhD is an Associate Professor in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute and she co-directs the PRecisiOn Medicine Translational Research (PROMoTeR) Center. She is a pharmacist, health policy scientist and...
Christine Lu, Co-Director of the PRecisiOn Medicine Translational Research (PROMoTeR) Center, Harvard Pilgrim Health Care
Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway
Bill Martin is the Chief Commercial Officer for Accredo. In this role, Mr. Martin is responsible forguiding the development and growth of the organizations overall specialty business with payers,pharmaceutical manufacturers, and distribution partners. He leads a team that is heavily focused...
Bill Martin, Vice President, Pharma Strategy and Account Management, Express Scripts and Accredo
John Maslowski serves as Fibrocell’s President & Chief Executive Officer. Previously, he was SVP of Scientific Affairs, with oversight of R&D, clinical and regulatory affairs, and formerly was VP of Operations with responsibility for manufacturing and quality operations. Prior to...
John Maslowski, CEO, Fibrocell Science Inc
Christina Matteucci, Market Access Head, Brazil, Bristol Myers Squibb
Kevin Mayo, Ex Senior Director, Global Patient (Market) Access - Commerical Strategy and Consumer Operations, Shire Pharmaceuticals
Michele McCourt is Senior Director of the CancerCare Co-Payment Assistance Foundation. In this role, Ms. McCourt has overall operational responsibility for the development of the foundation. With more than 27 years of experience in patient services, she has overseen the implementation of dozens of...
Michele McCourt, Director, Cancer Care Co-Payment Assistance Foundation
Sean McElligott, Director, Market Access, Janssen
Jim McKay, Director, Clinical Development and Medical Affairs, Sandoz
Timothy Miller, President, Chief Executive Officer and Director, Abeona Therapeutics Inc.
Responsible for leading Market Access BU including Pricing, Reimbursement, Health Economics, Government Affairs and Advocacy. Also Commercial strategies and activities.Master Degree in Pharmacoeconomic / Health EconomicsActed in the area of market access and pharmacoeconomics as independent...
Roberta Monteiro, Market Access and Commercial Director Brazil, Eisai
Ramaiah Muthyala, Professor/Director at University of Minnesota, Indian Organisation of Rare Diseases
Jeff Myers, CEO, Medicaid Health Plans of America
Former:1) Senior staff member at Canadian Medical Association - Manitoba Division. Negotiator for collective agreements, physician procedural fees, and private service agreements2) Executive Director, Manitoba Society of Pharmacists3) Public Affairs & Reimbursement, GlaxoSmithKlineCurrent:4)...
Douglas Nanton, Market Access and Government Affairs - Western Canada and Ottawa, Valeant Pharmaceuticals International
David B. Nash was named the Founding Dean of the Jefferson College of Population Health (JCPH) in 2008. This appointment caps a 25-year tenure on the faculty of Thomas Jefferson University. He is also the Dr. Raymond C. and Doris N. Grandon Professor of Health Policy. JCPH provides innovative...
David Nash, MD MBA, Dean/Board of Directors, Jefferson College of Population Health
Ms. Niles oversees relationships/partnerships with patient advocacy and professional organizations, as well as the Foundation’s public advocacy initiatives. Before joining the PAN Foundation, Ms. Niles served as Chair, Medical Relations and Advocacy for the Together Rx Access program. Prior to...
Amy Niles, Vice President, External Affairs, Patient Access Network Foundation P.A.N.
Meryem Nimour, VP- Medical Affairs Lead – Rare Disease- Emerging Markets,, Pfizer
Nneka C. Onwudiwe, PhD, PharmD, MBA received her doctorate in Pharmacy (PharmD) from the University of Maryland School of Pharmacy, PhD in Health Services Research with a specialization in Pharmacoeconomics from the University of Maryland School of Pharmacy, and a MBA (Honors) from the University...
Nneka Onwudiwe PharmD PhD MBA, PRO/PE Regulatory Reviewer, US Government
Melissa serves as the Oncology Patient Access Principal Coordinator at the Emily Couric Clinical Cancer Center, UVA Health System. She is responsible for patient access integration within the HCP and implementing all patient access programs across the spectrum, in the form of co-pay assistance...
Melissa Paige, UVA Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate, U.V.A. Health System
Sachin Palod, Vice President, Access & Value Solutions, Life Sciences, Optum Life Sciences
Leena Patel oversees donor relations and development at the Patient Access Network Foundation. As the Director of Development, Ms. Patel maintains the day-to-day communications with PAN’s donors, and also maintains existing and identifying new disease fund opportunities. Prior to joining the PAN...
Leena Patel, President and CEO, Patient Access Network Foundation
Edmund J. Pezalla, MD, MPHDr. Pezalla in a leading innovator and consultant on payer strategy for pharmaceutical and device manufacturers. He focuses on unlocking the value of new products by developing industry-leading approaches to incorporating payer requirements into development...
Edmund Pezalla, Former VP Pharmaceutical Policy and Strategy, Aetna
Lisa Phelps, Director Community Relations and Marketing, National Organization for Rare Disorders
A career public servant, Tanya Potashnik possesses a breadth of knowledge in the area of pharmaceutical environment in Canada both from a provincial and Federal perspective. Tanya is currently the Director of policy and economic analysis at the Patented Medicine Prices Review Board. Prior to this...
Tanya Potashnik, Director Policy & Economic Analysis, Patented Medicine Prices Review Board, Goverment Of Canada
S D Ravetkar, Executive Director, Serum Institute of India Ltd
Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines
Elizabeth Richardson, Managing Associate, Duke Margolis Center for Health Policy
Tehseen Salimi, Head of Medical Affairs-Primary Care and Women's Health, Merck
John Shea, Director Corporate Development, Merck & Co Inc
Vanja Sikirica, Senior Director of Value Evidence and Outcomes, GlaxoSmithKline
Jason C. Simeone, PhD, MS, is an epidemiologist and Research Scientist in the Real-World Evidence group at Evidera in Waltham, Massachusetts. Dr. Simeone’s experience is focused in the areas of pharmacoepidemiology, drug safety, and outcomes research, and he serves as principal investigator or...
Jason Simeone, Research Scientist, Real-World Evidence, Evidera
Dr. Jamie Skipper, RN, PhD, is currently a Healthcare/Health IT Policy Advisor and Strategist at Elevation Health Consulting where she advises public and private stakeholders across the healthcare arena to strategically improve health outcomes with a person-centric motto through...
Jamie Skipper, Former, ONC - Patient Centered Outcomes Research/HIT Policy, HSS
David Smith, Professor of Laboratory Medicine And Pathology, Mayo Clinic
Stephen Smith, Reimbursement Associate, Merck
Dr. Lotte Steuten is an entrepreneurial academic, striving to accelerate patient access to high-value healthcare innovations. She has deep expertise in health economics and evidence development that she applies to identifying and articulating the clinical, humanistic and economic value of medical...
Lotte Steuten, Associate Faculty Member, Fred Hutchinson Cancer Research Center
John Stoeckle, Physician, Thomas Jefferson University Hospitals, Inc.
Erika Szabo, Associate Director of Global Oncology, Teva Pharmaceuticals
Dr. Tang is the Senior Director and Head, Growth Markets of Global Health Economics and Outcomes Research (GHEOR) at Teva Pharmaceutical, responsible for health outcomes research in developing countries and Asia region. Dr. Tang has established the newly created Growth Markets Market Access and...
Dr Boxiong Tang, Senior Director, Teva Pharmaceuticals United State of America
Asif Velani, Head of Market Access, Puma
Christine Verini, Chief Business Development Officer, CancerCare
Jennifer Voelker, Post-doctoral HEOR fellow, Jansen
Bert Vrijhoef, CIO & Senior Principal Investigator, Panaxea & Maastricht Unniversity Medical Center
Meredith Wadman has covered biomedical research politics from Washington for twenty years. She is a reporter at Science and was formerly a reporter for Nature and a contributing writer at Fortune. Her opinion articles have appeared in the New York Times, the Washington Post and the Wall Street...
Meredith Wadman, Policy Reporter, Science Magazine and author: The Vaccine Race: Science, Politics and the Human Costs of Defeating Disease., Viking
Surrey Walton, PhD, is an Associate Professor in the Department of Pharmacy Systems Outcomes and Policy and Assistant Director of the Center for Pharmacoepidemiology and Pharmacoeconomic Research. Dr. Walton was a founding member of the Center for Pharmacoepidemiology and Pharmacoeconomic Research...
Surrey Walton, Associate Professor of Pharmacy Administration, U.I.C.
Christina Waters, President & Chief Executive Officer, R.A.R.E. Science
Durhane Wong-Rieger, PHD is Chair of Rare Disease International (the global alliance of rare disease patient organizations), Past-Chair of the International Alliance of Patient Organizations, member of the Editorial Board of The Patient- Patient Centred Outcomes Research and member of Health...
Durhane Wong-Rieger, President and Chief Executive Officer, Canadian Organization For Rare Disorders
James Wu, Senior Manager, Global Health Economics, Amgen Inc
Ying Wu, Director HEOR, Teva
George Wyatt, Managing Director and Founder, Wyatt Health